No Record Found
Sector
PharmaceuticalsOpen
₹848.1Prev. Close
₹844.2Turnover(Lac.)
₹8.35Day's High
₹860.05Day's Low
₹846.152 Week's High
₹1,54052 Week's Low
₹762.6Book Value
₹701.27Face Value
₹10Mkt Cap (₹ Cr.)
491.06P/E
76.57EPS
11.02Divi. Yield
0.59No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 5.71 | 5.71 | 5.71 | 5.71 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 386.78 | 377.27 | 305.87 | 273.76 | 
| Net Worth | 392.49 | 382.98 | 311.58 | 279.47 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Revenue | 320.79 | 287.45 | 295.32 | 322.6 | 
| yoy growth (%) | 11.59 | -2.66 | -8.45 | 0.25 | 
| Raw materials | -105.39 | -90.93 | -85.04 | -94.68 | 
| As % of sales | 32.85 | 31.63 | 28.79 | 29.35 | 
| Employee costs | -90.33 | -84.53 | -83.17 | -81.6 | 
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Profit before tax | 28.95 | 21.54 | 27.23 | 22.21 | 
| Depreciation | -7.67 | -8.23 | -7.51 | -8.99 | 
| Tax paid | -9.78 | -8.06 | -10.17 | -15.02 | 
| Working capital | -38.2 | -2.63 | -1.62 | 8.15 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 11.59 | -2.66 | -8.45 | 0.25 | 
| Op profit growth | 39.53 | -22.03 | -10.27 | -15.11 | 
| EBIT growth | 32.79 | -19.91 | 16.44 | 4.6 | 
| Net profit growth | 94.78 | -38.32 | -66.75 | 250.32 | 
No Record Found
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,655 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.1 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,602.4 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,446.6 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
A K Kothari
Non Executive Director
Prabhawati Devi Kothari
Independent Director
Monjori Mitra
Non Executive Director
Anand Vardhan Kothari
Managing Director & Chief Executive Officer
U. M. Kunte
Independent Director
Anurag Singhi
Independent Director
Shourya Sengupta
Independent Director
Naresh Pachisia
Additional Director
Rajiv Anant Desai
D Block 3rd Flr Gillander Hous,
Netaji Subhas Road,
West Bengal - 700001
Tel: 91-33-22302330/2262 8436/8456/
Website: http://www.albertdavidindia.com
Email: albertdavid@adlindia.in; abchakrabartty@adlindia.i
23 RN Mukherjee Road,
5th Floor,
Kolkata-700001
Tel: 91-33-22435029/22482
Website: www.mdpl.in
Email: info@mdpl.in
Summary
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal busi...
Read More
Reports by Albert David Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.